Ratio of oleic to palmitic acid is a dietary determinant of thrombogenic and fibrinolytic factors during the postprandial state in men

Am J Clin Nutr. 2006 Aug;84(2):342-9. doi: 10.1093/ajcn/84.1.342.

Abstract

Background: The nature of dietary fats affects the postprandial activation of the hemostatic system.

Objective: We investigated whether the ratio of oleic to palmitic acid [and that of monounsaturated to saturated fatty acids (MUFA:SFA)] in the diet affects postprandial concentrations of triacylglycerols, tissue factor (TF), fibrinogen, tissue-type plasminogen activator (t-PA), and plasminogen activator inhibitor 1 (PAI-1).

Design: We studied the effects of diets enriched in olive oil (ROO), high-palmitic sunflower oil (HPSO), butter, or a mixture of vegetable and fish oils (VEFO) on circulating concentrations of the aforementioned factors in 14 healthy men. The fats had ratios of oleic to palmitic acid (MUFA:SFA) of 6.83 (5.43), 2.36 (2.42), 0.82 (0.48), and 13.81 (7.08).

Results: The largest and longest-lasting postprandial changes in plasma triacylglycerol concentrations were found with the butter-based diet (all P < 0.05). No correlation was observed between the net incremental area under the curve (netAUC) for triacylglycerol and the ratio of oleic to palmitic acid (or MUFA:SFA) in the dietary fats. The netAUCs for TF and PAI-1, however, were inversely related to the ratio of oleic to palmitic acid (and MUFA:SFA) in ROO, HPSO, butter, and VEFO. Similar results were found for the fibrinogen netAUC when VEFO was omitted from the analysis. The netAUC for t-PA was inversely correlated with postprandial concentrations of triacylglycerol.

Conclusions: Postprandial concentrations of TF, fibrinogen, and PAI-1 are associated with the ratio of oleic to palmitic acid (MUFA:SFA) in dietary fats. The postprandial t-PA response is related to postprandial concentrations of triacylglycerol.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Area Under Curve
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / prevention & control
  • Cross-Over Studies
  • Dietary Fats / administration & dosage*
  • Dietary Fats / metabolism
  • Dietary Fats, Unsaturated / administration & dosage
  • Dietary Fats, Unsaturated / metabolism
  • Enzyme Inhibitors
  • Fibrinogen / metabolism*
  • Humans
  • Male
  • Oleic Acid / administration & dosage*
  • Oleic Acid / metabolism
  • Palmitic Acid / administration & dosage*
  • Palmitic Acid / metabolism
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Plasminogen Activators / metabolism
  • Postprandial Period*
  • Risk Factors
  • Thromboplastin / metabolism
  • Thrombosis / blood
  • Thrombosis / prevention & control
  • Triglycerides / blood*

Substances

  • Dietary Fats
  • Dietary Fats, Unsaturated
  • Enzyme Inhibitors
  • Plasminogen Activator Inhibitor 1
  • Triglycerides
  • Oleic Acid
  • Palmitic Acid
  • Fibrinogen
  • Thromboplastin
  • Plasminogen Activators